Team:
Advancing Regenerative Medicine
Eluciderm is guided by a multidisciplinary team of scientists, physicians, and biotechnology leaders focused on advancing regenerative medicine.
The company combines expertise in:
-
molecular biology and translational research
-
innovative clinical research
-
wound healing, regenerative and functional medicine
-
drug discovery and pharmaceutical development
This team is working to translate foundational biological discoveries into clinically deployable therapies that can improve how injured tissue heals.
With an expanding intellectual property portfolio and an advancing clinical development program, Eluciderm is focused on bringing the first therapies derived from its regenerative platform to patients while continuing to develop additional molecules that extend the platform’s regenerative and therapeutic potential.
Eluciderm Team
Dan Holsworth, PhD
CEO & CSO, Chairman of the Board
Dr. Daniel D. Holsworth is the Chief Executive Officer, Chief Scientific Officer, and Founder of Eluciderm, Inc. He is an entrepreneur, medicinal chemist, and expert in the field of drug discovery with over 30 years of experience, including multiple stints in senior level research and director positions in the Biotech and Pharma industries, most notably Amylin Pharmaceuticals and Pfizer Global Research & Development. His research projects over the years have focused on a variety of therapeutic areas ranging from oncology, cardiovascular, metabolic, and inflammation, to more recent efforts in the fields of dermatology, regenerative medicine, and wound healing. His work has culminated in over half a dozen clinical candidates. He is the inventor on 40 patents and author of over 100 publications, book chapters, and presentations. Dr. Holsworth earned his Doctorate in Synthetic Organic Chemistry from Wayne State University in Detroit, Michigan, and was a Post-Doctoral Fellow in Medicinal Chemistry at Parke-Davis Pharmaceuticals in Ann Arbor, Michigan.
Sarika Saraswati, PhD
VP Molecular Biology
Dr. Sarika Saraswati is the VP of Molecular Biology Division at Eluciderm Inc. She has more than 18 years of experience in studying biochemical and cellular aspects of human disease conditions that includes stem cells, regenerative medicine, wound healing and fibrosis. Currently, Dr. Saraswati also serves as a tenure track Assistant Professor at Tennessee State University. Her research has been continuously funded by National Institute of Health, American Association of Blood Banks, and American Heart Association in addition to Internal grants at Tennessee State University. Dr. Saraswati has received multiple honors and awards including Young Investigator Award at the International Innovations in Wound Healing Conference and multiple first place awards in oral/poster presentation at International and National Conferences. Dr. Saraswati earned her Doctorate in Biochemistry and Molecular Biology from University of Arkansas for Medical Sciences, Little Rock, AR and her Post-Doctoral training at Vanderbilt University Medical Center, Nashville, TN.
John P. Delgado, MD, FAAFP
CMO / Board Member
John P. Delgado, MD is the Chief Medical Officer and co-founder of Eluciderm, Inc. He has over 35 years of both research and clinical experience in the areas of Clinical Research, Family Medicine, obstetrics, functional medicine, Stem Cell and Regenerative Medicine, procedural medicine, sports medicine and health administration. He has served as the Medical Director and Principal Investigator at Velocity Clinical Research in both Grants Pass and Medford, Oregon. Additionally, Dr. Delgado has served as Chief of Obstetrics and Perinatology in Ashland, Oregon, and has been the principal investigator in over 250 clinical studies, including major studies with Harvard University, the Cleveland Clinic, Mayo Clinic and several other private organizations.
Dr. Delgado earned a bachelor’s degree in Biological Sciences at Stanford University, attended UCLA Medical School, and is Board Certified in Family Medicine with memberships in the Institute of Functional Medicine and the American Academy of Stem Cell Physicians.
Joseph Marino
CBO / Board Member
Joseph Marino serves as a Chief Business Officer and co-founder of Eluciderm, Inc. For the past 40+ years he has embodied the entrepreneurial spirit with an unmatched series of startup-to-sale successes in the alternative/renewable/sustainable energy sector. His unique abilities as CEO/President to identify market potential and juggle both technical & leadership responsibilities have allowed him to repeatedly create forward-thinking products, build dynamic teams, and develop lucrative market segments. To date he has launched and sold four energy-based companies, and he continues to run a fifth. Always on the lookout for a new challenge, in 2020 Mr. Marino jumped at the opportunity to help Eluciderm navigate the business side of the biotech/pharmaceutical world. In addition to more technical pursuits, Mr. Marino is also an avid real estate investor; the crown jewel of his portfolio is the historic Noyo Harbor Inn, a 152-year-old boutique establishment on the stunning Mendocino Coast.
John J. Cummings III JD
Seed Investor / Board Member
Prominent former New Orleans-based trial lawyer and highly accomplished investor, Mr. Cummings now devotes much of his time and resources to philanthropic endeavors and the implementation of effective corporate strategy for Eluciderm.
Clinical Advisory Team
Larry Pollack, MD, FACS
• Plastic Surgeon
• Wound Care Expert
Abby S. Van Voorhees, M.D.
• Professor and Chair of the Department of Dermatology, Eastern Virginia Medical School
• Editor in Chief of JAAD
David Armstrong, DPM, MD, PhD
• Clinical Fellow, USC Schaeffer Center
• Professor of Surgery, Keck School of Medicine of USC
• Director, Southwestern Academic Limb Salvage Alliance
• Ranked #1 Worlds Top Expert in Diabetic Foot Care
• Clinical Trial expert in DFU treatment
George Mueller, MD, FACS
• Bariatric / General Surgeon
• Wound Care Expert
Andrew Vardanian, MD
• Plastic Surgeon
• Associate Prof of Plastic Surgery, UCLA
• Scar / Burn Care Expert
• 2024 California Super Doctor List
Michael Stone, MD, MS, IFMCP
• Family Physician
• Functional Medicine International Speaker
• Wound Care Expert
Vickie Driver, DPM, MS, FACFAS
• System Chief, INOVA Wound Healing & Hyperbaric Medicine Center
• Professor, University of Virginia School of Medicine
• Chairperson, Board Of Directors, Wound Care Collaborative Community
Scientific Advisory Team
Jeffrey Davidson, PhD
• Wound Healing Expert. • Professor of Pathology, Microbiology and Immunology; Vanderbilt University Medical Center
Pampee P. Young,
MD, PhD
• Regenerative Medicine Expert.
• CSO American Red Cross;
Former Professor, Vanderbilt University Medical Center.
• Published seminal work on Wnt/β-catenin pathway as applicable to wound healing.
Justin Cates, MD, PhD
• Board Certified Pathologist.
• Professor of Pathology; Vanderbilt University Medical Center.
Darryl D’Lima MD, PhD
• Cartilage Regeneration Expert
• Director & Chair of Orthopedic Research at Shiley Center for Orthopedic Research and Education at Scripps Clinic
• Professor of Molecular Medicine at The Scripps Research Institute